Sector

Healthcare

One of the most prominent practices in Europe, on a growing resilient sector, underpinned by constant innovation in biotech and medtech, and long-term demand for healthcare services.

Bryan, Garnier & Co's insights and news

Read the latest news, reports and newsletters from Europe’s Growth Investment Bank to find out more about current trends impacting investment banking activity and company performance.

Healthcare transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co acts as Sole Financial Advisor, Joint Global Coordinator & Joint Bookrunner on Exact Therapeutics’ NOK 145m Follow-On Offering anchored for USD 7m by GE Healthcare

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on ONWARD Medical’s EUR 50m Follow-On Offering, anchored for EUR 22.5m by a Cornerstone Investment from Ottobock

Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on Egetis Therapeutics’ SEK 300 million Follow-On Offering

Bryan, Garnier & Co acts as Joint Global Coordinator & Joint Bookrunner on Valneva’s EUR 61.2m Follow-On Offering

Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Nicox’s Euronext Paris EUR 3.3m Rights Issue

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on Cinclus Pharma’s SEK 715m Nasdaq Stockholm IPO

Bryan, Garnier & Co acts as Sole Financial Advisor to German medical device CRO/CDMO seleon GmbH

Bryan, Garnier & Co acts as Sole Global Coordinator & Joint Bookrunner on ONWARD Medical’s EUR 20 million Follow-On Offering

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on GeNeuro’s EUR 5m Follow-on Offering

Bryan, Garnier & Co acts as Joint Bookrunner to Swedish biopharmaceutical company Camurus on a Follow-on Offering of SEK 1,090m

Bryan, Garnier & Co acts as Sole Financial Advisor to Calliditas Therapeutics AB on EUR 92m term loan facility from Athyrium Capital Management

Bryan, Garnier & Co acts as European Lead Manager on Abivax’s USD 236 million Nasdaq IPO

Bryan, Garnier & Co acts as Financial Advisor to the Boiron Family in the €875m tender offer for the BOIRON Group, world leader in natural medicine, in partnership with EW Healthcare Partners

Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner to Egetis Therapeutics on a Combined Offering of SEK 462m

Bryan, Garnier & Co acts as Sole Financial Advisor and Placement Agent to Abivax on two structured debt financing transactions for up to EUR 150 million

Bryan, Garnier & Co acts as Sole Global Coordinator & Sole Bookrunner on Median Technologies’ EUR 21.6 million Follow-On Offering & Convertible Bonds Issuance

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }